Lamothe Jeffrey G. has filed 18 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 17300 shares of Aptevo Therapeutics Inc. ($APVO) on August 06, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2025 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | A | Restricted Stock Unit | 17300 | $0.00 | 17,300.0000 | 1,458,445 | 9999.99% | 1.19% |
| July 17, 2025 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Common Stock (post-reverse split May ACTIVE) | 5 | $0.00 | 6.0000 | 1,458,445 | 500.00% | 0.00% |
| July 17, 2025 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Restricted Stock Unit | 5 | $0.00 | 12.0000 | 1,458,445 | 29.41% | 0.00% |
| March 2, 2025 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Common Stock | 3 | $0.00 | 34.0000 | 1,458,445 | 9.68% | 0.00% |
| March 3, 2025 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Common Stock | 2 | $0.00 | 36.0000 | 1,458,445 | 5.88% | 0.00% |
| March 2, 2025 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Restricted Stock Unit | 3 | $0.00 | 4.0000 | 1,458,445 | 42.86% | 0.00% |
| March 3, 2025 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Restricted Stock Unit | 2 | $0.00 | 0.0000 | 1,458,445 | 100.00% | 0.00% |
| Aug. 8, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Common Stock | 42 | $0.00 | 894.0000 | 0 | 4.93% | 0.00% |
| Aug. 8, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Common Stock | 272 | $0.00 | 1,166.0000 | 0 | 30.43% | 0.00% |
| Aug. 8, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Restricted Stock Unit | 42 | $0.00 | 41.0000 | 0 | 50.60% | 0.00% |
| Aug. 8, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Restricted Stock Unit | 272 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 17, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | A | Restricted Stock Unit | 12825 | $0.00 | 12,825.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Common Stock | 5500 | $0.00 | 33,837.0000 | 0 | 19.41% | 0.00% |
| March 3, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Common Stock | 3667 | $0.00 | 37,504.0000 | 0 | 10.84% | 0.00% |
| March 2, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Restricted Stock Unit | 5500 | $0.00 | 11,000.0000 | 0 | 33.33% | 0.00% |
| March 3, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Restricted Stock Unit | 3667 | $0.00 | 3,667.0000 | 0 | 50.00% | 0.00% |
| Jan. 28, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Common Stock | 1833 | $0.00 | 28,337.0000 | 0 | 6.92% | 0.00% |
| Jan. 28, 2024 | Aptevo Therapeutics Inc. | $APVO | Lamothe Jeffrey G. | EVP, COO | M | Restricted Stock Unit | 1833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |